Covaxin Trials On Minors
- All
- News
-
Covaxin Trials Among Children A Big Hit At AIIMS Patna. Because...
- Friday June 18, 2021
- India News | Reported by Manish Kumar, Edited by Ashutosh Tripathi
Doctors at the All India Institute of Medical Sciences (AIIMS) Patna are coming forward with their children to take part in Bharat Biotech's Covaxin trails on minors at the premier institute, blunting doubts on vaccine hesitancy.
- www.ndtv.com
-
Covaxin Trial On 2-18 Year Olds "Amounts To Homicide": Plea In Delhi High Court
- Thursday June 3, 2021
- India News | Press Trust of India
A plea has been moved in the Delhi High Court seeking stay on the phase II/III clinical trials of Covaxin - Bharat Biotech's Covid Vaccine - on 2-18 year olds.
- www.ndtv.com
-
Centre's Stand Sought On Plea Against Covaxin Trial On 2-18 Age Group
- Wednesday May 19, 2021
- India News | Press Trust of India
A plea to set aside the permission granted by the Drugs Controller General to Bharat Biotech for conducting phase II/III clinical trial of its Covaxin COVID-19 vaccine on the 2-18 age group was heard by the high court which sought Centre's stand.
- www.ndtv.com
-
Covaxin Trials Among Children A Big Hit At AIIMS Patna. Because...
- Friday June 18, 2021
- India News | Reported by Manish Kumar, Edited by Ashutosh Tripathi
Doctors at the All India Institute of Medical Sciences (AIIMS) Patna are coming forward with their children to take part in Bharat Biotech's Covaxin trails on minors at the premier institute, blunting doubts on vaccine hesitancy.
- www.ndtv.com
-
Covaxin Trial On 2-18 Year Olds "Amounts To Homicide": Plea In Delhi High Court
- Thursday June 3, 2021
- India News | Press Trust of India
A plea has been moved in the Delhi High Court seeking stay on the phase II/III clinical trials of Covaxin - Bharat Biotech's Covid Vaccine - on 2-18 year olds.
- www.ndtv.com
-
Centre's Stand Sought On Plea Against Covaxin Trial On 2-18 Age Group
- Wednesday May 19, 2021
- India News | Press Trust of India
A plea to set aside the permission granted by the Drugs Controller General to Bharat Biotech for conducting phase II/III clinical trial of its Covaxin COVID-19 vaccine on the 2-18 age group was heard by the high court which sought Centre's stand.
- www.ndtv.com